CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $391,200
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$391,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-13 | Mounts Phoebe General Counsel | Purchase | +2,525 | $4.03 | $10K | 7,200 |
| 2020-08-13 | Kaplan Myron Director | Purchase | +15,000 | $4.08 | $61K | 134,734 |
| 2020-08-13 | Baluch Khoso Chief Executive Officer | Purchase | +4,830 | $4.14 | $20K | 60,905 |
| 2020-08-12 | DUNTON ALAN W Director | Purchase | +5,000 | $3.95 | $20K | 6,250 |
| 2020-05-15 | Dillione Janet Director | Grant or award · Phantom Stock | +5,253 | 5,253 | ||
| 2020-05-15 | Kaplan Myron Director | Purchase | +10,000 | $3.85 | $39K | 119,734 |
| 2020-05-11 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Grant or award · Stock Option (Right to Buy Common Stock) | +37,500 | $5.63 | $211K | 37,500 |
| 2020-05-11 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Grant or award · Stock Option (Right to Buy Common Stock) | +37,500 | $4.08 | $153K | 37,500 |
| 2020-05-11 | Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +37,500 | $5.63 | $211K | 37,500 |
| 2020-05-11 | Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +37,500 | $4.08 | $153K | 37,500 |
| 2020-05-11 | Mounts Phoebe General Counsel | Grant or award · Stock Option (Right to Buy Common Stock) | +50,000 | $5.63 | $282K | 50,000 |
| 2020-05-11 | Mounts Phoebe General Counsel | Grant or award · Stock Option (Right to Buy Common Stock) | +50,000 | $4.08 | $204K | 50,000 |
| 2020-05-11 | David Matthew T EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | $5.63 | $704K | 125,000 |
| 2020-05-11 | David Matthew T EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | $4.08 | $510K | 125,000 |
| 2020-03-18 | Mounts Phoebe General Counsel | Purchase | +3,250 | $3.05 | $10K | 4,675 |
| 2020-03-18 | Baluch Khoso Chief Executive Officer | Purchase | +3,500 | $2.61 | $9K | 56,075 |
| 2020-02-25 | Lefkowitz Steven W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +15,000 | $5.63 | $84K | 15,000 |
| 2020-02-25 | Dillione Janet Director | Grant or award · Stock Option (Right to Buy Common Stock) | +15,000 | $5.63 | $84K | 15,000 |
| 2020-02-25 | Khan Mehmood Director | Grant or award · Stock Option (Right to Buy Common Stock) | +15,000 | $5.63 | $84K | 15,000 |
| 2020-02-25 | Mounts Phoebe General Counsel | Grant or award · Stock Option (Right to Buy Common Stock) | +24,764 | $5.63 | $139K | 24,764 |
Page 13 of 16 · 301 trades